Sermorelin/GHRP-2 18 mg/6 mg powder recalled over sterility concerns
- Recall date
- September 10, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharm D Solutions, LLC recalls Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10
- Recall number
- D-0181-2019
- FDA classification
- Class II
- Brand / firm
- Pharm D Solutions, LLC
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10
Get recall alerts
Free email alert whenever Pharm D Solutions, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharm D Solutions, LLC